Up­dat­ed: FDA ap­proves Pfiz­er’s Pre­vnar 20 for in­fants and chil­dren

Pfiz­er has se­cured ap­proval from the FDA for its Pre­vnar 20 pneu­mo­coc­cal dis­ease vac­cine for in­fants, chil­dren and ado­les­cents, the New York-based drug­mak­er an­nounced Thurs­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER